Tacrolimus and pimecrolimus in dermatology. Part II. Treatment of other skin diseases;Takrolimus i pimekrolimus w dermatologii. Cz. II. Leczenie innych niż azs chorób skóry

Przeglad Dermatologiczny

Volumn 91, Issue 5, 2004, Pages 371-382

  Wolska, Hanna ^a,b   Błaszczyk, Maria ^a,b  

^a Klinika Dermatologiczna AM Warszawie   (Poland)

^b Klinika Dermatologiczna Medical University of Warsaw   (Poland)

Author keywords

Immunomodulatory macrolides; Pimecrolimus; Tacrolimus; Topical therapy

Indexed keywords

PIMECROLIMUS; TACROLIMUS;

ATOPIC DERMATITIS; BULLOUS DERMATITIS; CLINICAL TRIAL; DERMATOMYOSITIS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EYELID DISEASE; GRAFT VERSUS HOST REACTION; HAND DISEASE; HUMAN; LEUKOPENIA; LICHEN PLANUS; LICHEN SCLEROSUS ET ATROPHICUS; NONHUMAN; PEMPHIGOID; PEMPHIGUS VULGARIS; PSORIASIS; REVIEW; ROSACEA; SEBORRHEIC DERMATITIS; SIDE EFFECT; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 9944232587     PISSN: 00332526     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (105)

1. Wolska H., Błaszczyk M.: Takrolimus i pimekrolimus w dermatologii. Cz. I. Leczenie atopowego zapalenia skóry. Przegl Dermatol 2004, 91, 199-208.
2. Lauerma A.I., Maibach H.I., Granlund H. i inni: Inhibition of contact allergy reactions by topical FK506. Lancet 1992, 340, 556.
3. Meingassner J.G., Stutz A.: Immunosuppressive macrolides of the type FK506: a novel class of topical agents for treatment of skin diseases? J Invest Dermatol 1992, 98, 851-855.
4. Saripalli Y.V., Gadzia J.E., Belsito D.V.: Tacrolimus ointment 0.1% in the treatment of nickel-induced allergic contact dermatitis. J Am Acad Dermatol 2003, 49, 477-482.
5. Schnopp Ch., Remling R., Mohrenschlager M. i inni: Topical tacrolimus (FK506) and mometasone fuorate in treatment of dyshidrotic palmar eczema: a randomized, observer-blinded trial. J Am Acad Dermatol 2002, 46, 73-77.
6. Rikkers S.M., Holland G.N., Drayton G.E. i inni: Topical tacrolimus treatment of atopic eyelid disease. Am J Ophthalmol 2003, 135, 297-302.
7. Krupnick A., Serle J., van Veldhuisen P. i inni: Tacrolimus ointment for the treatment of eyelid dermatitis. Ann Dermatol Venereol 2002, 129, 1S415.
8. Goldman D.: Tacrolimus ointment for the treatment of steroid-induced rosacea: a preliminary report. J Am Acad Dermatol 2001, 44, 995-998.
9. st Annual Meeting Am Acad Dermatol, San Francisco, USA, 2003, Book of Abstracts P311.
10. Pabby A., An K.P., Laws R.A.: Combination therapy of tetracycline and tacrolimus resulting in rapid resolution of steroid - induced periocular rosacea. Cutis 2003, 72, 141-142.
11. Bamford J.T., Ellioti B.A., Haller I.V.: Tacrolimus effect on rosacea. J Am Acad Dermatol 2004, 50, 107-108.
12. st Annual Meeting of the Am Acad Dermatol, San Francisco, USA, 2003, Book of Abstracts P90.
13. Antille Ch., Saurat J.H., Lubbe J.: Induction of rosaceiform dermatitis during treatment of facial inflammatory dermatoses with tacrolimus ointment. Arch Dermatol 2004, 140, 457-460.
14. Milingou M., Antille C., Saurat J.H. i inni: Alcohol intolerance in adult patients with atopic dermatitis treated with 0.1% tacrolimus ointment. J Eur Acad Dermatol Venereol 2003, 17, supl. 3, 462.
15. Lubbe J., Stucky L., Saurat J.H.: Rosaceiform dermatitis with follicular demodex after treatment of facial atopic dermatitis with 1% pimecrolimus cream. Dermatology 2003, 207, 205-207.
16. Uetsu N., Okamoto H., Fujii K. i inni: Treatment of chronic actinic dermatitis with tacrolimus ointment. J Am Acad Dermatol 2002, 47, 881-884.
17. Abe R., Shimizu T., Tsuji A. i inni: Severe refractory chronic actinic dermatitis successfully treated with tacrolimus ointment. Br J Dermatol 2002, 147, 1273-1275.
18. Suga Y., Hashimoto Y., Matsuba S. i inni: Topical tacrolimus for chronic actinic dermatitis. J Am Acad Dermatol 2002, 46, 321-323.
19. Ogawa Y., Adachi A., Tomita Y.: The successful use of topical tacrolimus treatment for a chronic actinic dermatitis patient with complications of idiopathic leukopenia. J Dermatol 2003, 30, 805-809.
20. Evans A.V., Palmer R.A., Hawk J.L.M.: Erythrodermic chronic actinic dermatitis responding only to topical tacrolimus. Photodermatol Photoimmunol Photomed 2004, 20, 59-61.
21. Fujimoto N., Tajima S., Ishibashi A.: Facial lichen striatus: successful treatment with tacrolimus ointment. Br J Dermatol 2003, 148, 587-590.
22. Nagagawa H., Etoh T., Yakota Y. i inni: Tacrolimus has antifungal activities against Malassezia furfur isolated from healthy adults and patients with atopic dermatitis. Clin Drug Invest 1996, 12, 245-250.
23. Braza T.J., Dicarlo J.B., Soon S.L. i inni: Tacrolimus 0.1% ointment for seborrhoeic dermatitis an open-label pilot study. Br J Dermatol 2003, 148, 1242-1244.
24. Meshkinpour A., Sun J., Weinstein G.: An open pilot study using tacrolimus ointment in the treatment of seborrheic dermatitis. J Am Acad Dermatol 2003, 49, 145-147.
25. Yamamoto T., Nishioka K.: Topical tacrolimus an effective therapy for facial psoriasis. Eur J Dermatol 2003, 13, 471-473.
26. Krupnick Freeman A., Linowski G.J., Brady Ch. i inni: Tacrolimus ointment for the treatment of psoriasis on the face and intertrigionous areas. J Am Acad Dermatol 2003, 48, 564-568.
27. Clayton T.H., Harrison P.V., Nicholls R. i inni: Topical tacrolimus for facial psoriasis. Br J Dermatol 2003, 149, 419-420.
28. Zonneveld I.M., Rubins A., Jablonska S. i inni: Topical tacrolimus is not effective in chronic plaque psoriasis. A pilot study. Arch Dermatol 1998, 134, 1101-1102.
29. Remitz A., Reitamo S., Erkko P. i inni: Tacrolimus ointment improves psoriasis in a microplaque assay. Br J Dermatol 1999, 141, 101-107.
30. Ishiko A., Yokoyama T., Tanikawa A. i inni: A case of generalized pustular psoriasis treated with topical tacrolimus. Arch Dermatol 2003, 139, 1219.
31. Wilsmann-Theis D., Hagemann T., Dederer H. i inni: Successful treatment of acrodermatitis continua suppurativa with topical tacrolimus 0.1% ointment. Br J Dermatol 2004, 150, 1194-1197.
32. Smith D.A., Tofte S.J., Hanifin J.M.: Repigmentation of vitiligo with topical tacrolimus. Dermatology 2002, 205, 301-303.
33. Grimes P.E., Soriano T., Dytoc M.T.: Topical tacrolimus for repigmentation of vitiligo. J Am Acad Dermatol 2002, 47, 789-791.
34. Tanghetti E.A.: Tacrolimus ointment 0.1% produces repigmentation in patients with vitiligo: results of a prospective patient series. Cutis 2003, 71, 158-162.
35. Travis L.B., Weinberg J.M., Silverberg N.B.: Successful treatment of vitiligo with 0.1% tacrolimus ointment. Arch Dermatol 2003, 139, 571-574.
36. Lepe V., Moncado B., Cazares J.P. i inni: A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. Arch Dermatol 2003, 139, 581-585.
37. Grimes P.E., Morris R., Avaniss-Aghajani E. i inni: Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines. J Am Acad Dermatol 2004, 51, 52-61.
38. st Annual Meeting Am Acad Dermatol, San Francisco, USA, 2003, Book of Abstracts P579.
39. Kawalek A.Z., Spencer J.M., Phelps R.G.: Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study. Dermatol Surg 2004, 30, 130-135.
40. Niwa Y., Terashima T., Sumi H.: Topical application of the immunosuppressant tacrolimus accelerates carcinogenesis in mouse. Br J Dermatol 2003, 149, 960-967.
41. Vente C., Reich K., Rupprecht R. i inni: Erosive mucosal lichen planus: response to topical treatment with tacrolimus. Br J Dermatol 1999, 140, 338-342.
42. Kaliakatsou F., Hodgson T.A., Lewsey J.D. i inni: Management of recalcitrant ulcerative oral lichen planus with topical tacrolimus. J Am Acad Dermatol 2002, 46, 35-41.
43. Morrison L., Kratochvil F.J., German A.: An open trial of topical tacrolimus for erosive oral lichen planus. J Am Acad Dermatol 2002, 47, 617-620.
44. Rozycki T.W., Rogers III R.S., Pittelkow M.R. i inni: Topical tacrolimus in the treatment of symptomatic oral lichen planus: a series of 13 patients. J Am Acad Dermatol 2002, 46, 27-34.
45. Hodgson T.A., Sahni N., Kaliakatsou F. i inni: Long-term efficacy and safety of topical tacrolimus in the management of ulcerative/erosive oral lichen planus. Eur J Dermatol 2003, 13, 406-470.
46. Kirtschig G., Van Der Meulen A.J., Ion Lipan J.W. i inni: Successful treatment of erosive vulvovaginal lichen planus with topical tacrolimus. Br J Dermatol 2002, 147, 625-626.
47. Kist J., Fiore J.: Treatment of erosive lichen planus of the penis with topical tacrolimus. Ann Dermatol Venereol 2002, 129, 1S700.
48. Watsky K.: Erosive perianal lichen planus responsive to tacrolimus. Int J Dermatol 2003, 42, 217-218.
49. Nazzari G., Cestari R.: Topical tacrolimus ointment in ulcerative lichen planus: an alternative therapeutic approach. Eur J Dermatol 2002, 12, 321.
50. Frieling V., Bonsmann G.: Topical treatment of lichen sclerosus et atrophicans in the genitoanal area with tacrolimus (FK506, protopic). Munsteraner Diaklinic 5 Juni 2002.
51. Kunstfeld R., Kirnbauer R., Stingl G. i inni: Successful treatment of vulvar lichen sclerosus with topical tacrolimus. Arch Dermatol 2003, 139, 850-852.
52. Assmann T., Becker-Wegerich P., Grewe M. i inni: Tacrolimus ointment for treatment of vulvar lichen sclerosus. J Am Acad Dermatol 2003, 48, 935-937.
53. Bohm M., Frieling U., Luger T.A. i inni: Successful treatment of anogenital lichen sclerosus with topical tacrolimus. Arch Dermatol 2003, 139, 922-924.
54. st Annual Meeting of the Am Acad Dermatol, San Francisco, USA, 2003, Book of Abstracts P299.
55. Choi C.J., Nghiem P.: Tacrolimus ointment in the treatment of chronic cutaneous graft-vs-host disease. Arch Dermatol 2001, 137, 1202-1206.
56. Elad S., Or R., Resnick I. i inni: Topical tacrolimus: a novel treatment alternative for cutaneous chronic graft-versus host disease. Transpl Int 2003, 16, 665-670.
57. Böhm M., Gaubitz M., Luger T. i inni: Topical tacrolimus as a therapeutic adjunct in patients with cutaneous lupus erythematosus. Dermatology 2003, 207, 381-385.
58. Kanekura T., Yoshii N., Terasaki K. i inni: Efficacy of topical tacrolimus for treating the malar rash of systemic lupus erythematosus. Br J Dermatol 2003, 148, 353-356.
59. Yoshimasu T., Ohtani T., Sakamoto T. i inni: Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis. Eur J Dermatol 2002, 12, 50-52.
60. th Annual Scientific Meeting, New Orleans, 2002, S306.
61. Ueda M., Makinodan R., Matsumura M. i inni: Successful treatment of amyopathic dermatomyositis with topical tacrolimus. Br J Dermatol 2003, 148, 595-596.
62. Mancuso G., Berdondini M.: Topical tacrolimus in the treatment of localized scleroderma. Eur J Dermatol 2003, 13:590-591.
63. Hall V.C., Liesegang Th.J., Kostick D.A. i inni: Ocular mucous membrane pemphigoid and ocular pemphigus vulgaris treated topically with tacrolimus ointment. Arch Dermatol 2003, 139, 1083-1084.
64. Hodgson T., Malik F., Hegarty A.M. i inni: Topical tacrolimus: a novel therapeutic intervention for recalcitrant labial pemphigus vulgaris. Eur J Dermatol 2003, 13, 142-144.
65. Gach J.E., Ilchyshyn A.: Beneficial effects of topical tacrolimus on recalcitrant erosions of pemphigus vulgaris. Clin Exp Dermatol 2004, 29, 271-272.
66. Vecchietti G., Kerl K., Hugli A. i inni: Topical tacrolimus (FK506) for relapsing erosive stomatitis in paraneoplastic pemphigus. Br J Dermatol 2003, 148, 833-834.
67. Ko M.J., Chu C.Y.: Topical tacrolimus therapy for localized bullous pemphigoid. Br J Dermatol 2003, 149, 1077-1078.
68. Chu J., Bradley M., Marinkovich M.P.: Topical tacrolimus is a useful adjunctive therapy for bullous pemphigoid. Arch Dermatol 2003, 139, 813-815.
69. Chuh A.A.T.: The application of topical tacrolimus in vesicular pemphigoid. Br J Dermatol 2004, 150, 622-623.
70. Gunther C., Wozel G., Meurer M. i inni: Topical tacrolimus treatment for cicatricial pemphigoid. J Am Acad Dermatol 2004, 50, 325-326.
71. Liu Z., Diaz L.A.: Buollous pemphigoid: end of the century overview. J Dermatol 2001, 28, 647-650.
72. Giomi B., Caproni M., Calzolari A. i inni: Th1, Th2 and Th3 cytokines in the pathogenesis of bullous pemphigoid. J Dermatol Sci 2002, 30, 116-128.
73. Chorzelski T.: Experimetally induced acantholysis in Hailey's benign pemphigus. Dermatologica 1962, 124, 21-30.
74. Rabeni E.J., Cunningham N.M.: Effective treatment of Hailey-Hailey disease with topical tacrolimus. J Am Acad Dermatol 2002, 47, 797-798.
75. Sand C., Thomsen U.K.: Topical tacrolimus ointment is and effective therapy for Hailey-Hailey disease. Arch Dermatol 2003, 139, 1401-1402.
76. Banky J.P., Sheridan A.T., Storer E.L. i inni: Successful treatment of epidermolysis bullosa pruriginosa with topical tacrolimus. Arch Dermatol 2004, 140, 794-796.
77. Abu-Elmagd K., Jegasothy B.V., Ackerman C.D. i inni: Efficacy of FK506 in the treatment of recalcitrant pyoderma gangrenosum. Transplan Proc 1991, 23, 3328-3329.
78. Neumann Ch., Vente C., Reich K.: Treatment of pyoderma gangrenosum with topical tacrolimus. J Invest Dermatol 1998, 110, 686.
79. Reich K., Vente C., Neumann C.: Topical tacrolimus for pyoderma gangrenosum. Br J Dermatol 1998, 139, 755-757.
80. Schuppe U.C., Homey B., Assmann T. i inni: Topical tacrolimus for pyoderma gangrenosum. Lancet 1998, 351, 832.
81. Jolles S., Niclasse S., Benson E.: Combination of oral and topical tacrolimus in therapy - resistant pyoderma gangrenosum. Br J Dermatol 1999, 140, 564-565.
82. Richter-Hintz D., Schuppe H.C., Homey B. i inni: Topical tacrolimus (FK506) is effective in the treatment of pyoderma gangrenosum. J Am Acad Dermatol 2000, 42, 304-305.
83. Lyon C.C., Stapleton M., Smith A.J. i inni: Topical tacrolimus in the management of peristomal pyoderma gangrenosum. J Dermatol Treat 2001, 12, 13-17.
84. Kimble R.M., Tickler A.K., Nicholls V.S. i inni: Successful topical tacrolimus (FK506) therapy in a child with pyoderma gangrenosum. J Pediatr Gastroenterol Nutr 2002, 34, 555-557.
85. Ghislain P.D., de Decker I., Marot L. i inni: Efficacy and systemic absorption of topical tacrolimus used in pyoderma gangrenosum. Br J Dermatol 2004, 150, 1052-1053.
86. Vidal D., Alomar A.: Successful treatment of peristomal pyoderma gangrenosum using topical tacrolimus. Br J Dermatol 2004, 150, 387-388.
87. Katoh N., Mihara H., Yasuno H.: Cutaneous sarcoidosis successfully treated with topical tacrolimus. Br J Dermatol 2002, 147, 154-156.
88. Clatyon T.C., Harrison P.V.: Topical tacrolimus for ulcerative necrobiosis lipoidica. Eur J Dermatol 2002, 16, supl. 1, 261.
89. Harth W., Linse R.: Topical tacrolimus in granuloma annulare and necrobiosis lipoidica. Br J Dermatol 2004, 150, 792-794.
90. Jain S., Stephens C.J.M.: Successful treatment of disseminated granuloma annulare with topical tacrolimus. Br J Dermatol 2004, 150, 1042-1043.
91. Rubegni P., Sbano P., Risulo M. i inni: A case of reticular erythematous mucinosis treated with topical tacrolimus. Br J Dermatol 2004, 150, 173-174.
92. Castanedo-Cazares J.P., Lepe V., Moncada B.: Lichen amyloidosus improved by 0.1% topical tacrolimus. Dermatology 2002, 205, 420-421.
93. Mallipeddi R., Evans AV.: Refractory pityriasis lichenoides chronica successfully treated with topical tacrolimus. Clin Exp Dermatol 2003, 28, 456-458.
94. Pauli-Magnus C., Klumpp S., Alscher D.M.: Short-term efficacy of tacrolimus ointment in severe uremic pruritus. Perit Dial Int 2000, 20, 802-803.
95. st Annual Meeting of the Am Acad Dermatol, San Francisco, USA, 2003, Book of Abstracts 486.
96. Edmonds E.V.J., Riaz S.N., Francis N. i inni: Nodular prurigo responding to topical tacrolimus. Br J Dermatol 2004, 150, 1216-1217.
97. Russell R.K., Richardson N., Wilson D.C.: Systemic absorption with complications during topical tacrolimus treatment for orofacial Crohn disease. J Pediatr Gastroenterol Nutr 2001, 32, 207-208.
98. Belsito D.V., Fowler J.F., Marks J.G. i inni: Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis. Cutis 2004, 73, 31-38.
99. Crutchfield III Ch.: Pimecrolimus: a new treatment for seborrheic dermatitis. Cutis 2002, 70, 207-208.
100. Brownell I., Quan L.T., Hsu S.: Topical pimecrolimus in the treatment of seborrheic dermatitis. Dermatol Online J 2003, 9, no 3.
101. Esqaivel-Pedraza L., Fernandez-Cuevas L., Ortiz-Pedroza G. i inni: Treatment of oral lichen planus with topical pimecrolimus 1% cream. Br J Dermatol 2004, 150, 771-773.
102. Dissemond J., Schroter S., Franckson T. i inni: Pimecrolimus in an adhesive ointment as a new treatment option for oral lichen planus. Br J Dermatol 2004, 150, 782-784.
103. Goldstein A.T., Marinoff S.C., Chrostopher K.: Pimecrolimus for the treatment of vulvar lichen sclerosus in a premenarchal gril. J Pediatr Adolesc Gynecol 2004, 17, 35-37.
104. Mayoral F.A., Gonzalez C., Shah N.S. i inni: Repigmentation of vitiligo with pimecrolimus cream: a case report. Dermatology 2003, 207, 322-323.
105. Ziemer M., Gruhn B., Thiele J.J. i inni: Treatment of extensive chronic cutaneous graft-versus-host disease in an infant with topical pimecrolimus. J Am Acad Dermatol 2004, 50, 946-948.